Chinese contract research organization (CRO) Biocytogen has raised a RMB543 million ($78 million) Series D round led by China Life Insurance and SDIC Venture Capital, a VC arm of the State Development & Investment Corporation (SDIC).
Existing investors CMB International – an investment arm of China Merchants Bank – Materia Medica Capital, and 3E Bioventures also participated in the funding round, according to a release. All three...
CHAMP Private Equity became CPE Capital earlier this year, following a leadership transition. The Australian GP has also refined its middle market investment strategy, emphasizing functional expertise
Difficult economic and political conditions bode well for the Korean PE industry in the near term, according to Michael Chung (pictured), head of Korea at Morgan Stanley Private Equity Asia (MSPEA).
Japan’s Daiwa Securities and Mitsubishi UFJ Financial Group have joined a $50 million Series C round for Malaysian used car trading platform Carsome.
AltStory, a Chinese interactive movie and television content company, has raised approximately RMB100 million ($14 million) in Series A funding led by China Literature, a listed unit of Tencent Holdings.